Track the Longboard Pharmaceuticals, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 2 December 2024 (U). Among the most active insiders: Kaye Randall. The full history is accessible without an account.
11
Insider Decl.
n/a
Thresholds
€2,281
1 ops.
Buy Volume
€89m
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Longboard Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
30Σ signal
Buys €2,281€89m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,978,540 shares@ US$24.25100.0% of flowVoting Common StockSEC:0000078003-24-000012:0
11 of 11 declarations
About Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders. It is listed on NASDAQ under the ticker symbol LBPH.